Respiratory Syncytial Virus Prophylaxis Season Reopening Across All Regions The Texas Health and Human Services Commission (HHSC) is aware of a summertime RSV resurgence in multiple regions across the state. In response to this RSV activity and consultation with medical experts from across the state, HHSC will take necessary action to prevent the further spread of RSV by reopening all regions to monthly administration of palivizumab (Synagis) prophylaxis to eligible members, starting June 1, 2022. Other news Moderna COVID-19 Vaccine Booster Dose Update Pfizer COVID-19 Vaccine Booster Dose for Children Update Members Sought for the Drug Utilization Review Board until June 1

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to ooseims.archieves@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202